News

STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs) STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs)

STEMCELL Technologies Launches Innovative Products to Support CAR T Cell Research STEMCELL Technologies Inc. announces the launch of ImmunoCult™ Human T Cell Activator reagents and ImmunoCult™-XF T Cell Expansion Medium to support T cell researchers in their goal to develop CAR T cell immunotherapeutics

STEMCELL Technologies Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems STEMCELL Technologies has entered into an exclusive licensing agreement with the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences for the rights to develop products for cerebral organoid culture

STEMCELL Technologies Will Test BioLife Solutions' evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App BioLife Solutions Inc. announced that privately held, Vancouver, BC-based STEMCELL Technologies will test BioLife's evo Smart Shipper and biologistex cold chain SaaS on a variety of temperature sensitive products for research in areas such as cellular therapies, blood cancers, and solid tumors

STEMCELL Technologies to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity STEMCELL Technologies has announced that it has signed a license agreement with the Salk Institute for Biological Studies for the rights to commercialize BrainPhys™ Neuronal Medium

STEMCELL Technologies Receives ISO 13845:2003 Certification STEMCELL Technologies Inc (STEMCELL), a leader in specialty cell culture media, cell separation products and ancillary reagents for life science research, is pleased to announce that it has successfully achieved ISO 13485:2003 certification for its research, manufacturing and shipping facilities in Vancouver, BC, Canada and Tukwila, WA, USA

ENKAM Pharmaceuticals A/S Commercial Partnership with STEMCELL Technologies Inc ENKAM Pharmaceuticals A/S (ENKAM), a privately held Danish biopharmaceutical development company focused on cancer and central nervous system disorders, is pleased to announce that it has signed a licensing and development agreement with STEMCELL Technologies Inc.

STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies STEMCELL Technologies has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.'s patented technologies for induced pluripotent stem cell (iPS cell) research

STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology that will Enable Advancements in the Study of the Immune Response to HIV and the Development of HIV Vaccines STEMCELL Technologies announced that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) will provide up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research as well as broader research in infectious disease

The HUB Foundation for Organoid Technology and STEMCELL Technologies Sign Agreement on the Manufacturing of Cell Culture Media for Organoids The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids

STEMCELL Technologies wins Support from Western Innovation (WINN) Initiative for Commercialization of 3D Cell Culture Platform STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture

STEMCELL Technologies Named Company of the Year by BIOTECanada STEMCELL Technologies Inc. will be presented with the Biotech Company of the Year award by BIOTECanada at the BIO International Convention in Philadelphia